Clinical Trial Update: Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure [Phase 4]

View source ↗

Summary

APhase 4 trial comparing intravenous vasodilator versus inotropic therapy in acute heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Montefiore Medical Center | Conditions: Acute Heart Failure | Phase 4 | Status: WITHDRAWN